The Patent Finder

Abbott Laboratories GmbH

Also on record
Records under this name other than patents Abbott Laboratories GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Abbott Laboratories GmbH

PatentTitleStatus Expires Confidence
US 11,278,603Enzyme Compositions with Reduced Viral and Microbial Contamination
Formerly held
In force
 · High confidence
In forceHigh confidence
US 6,300,336Method of treating or inhibiting functional disturbances or illnesses of the lower intestinal tracts, particularly abdominal visceral pain which accompanies them
Term ended
Term ended Mar 15, 2020 · From the USPTO record
Term endedTerm ended Mar 15, 2020From the USPTO record
US 6,069,147Thermogenesis stimulating drugs
Formerly held
Term ended
Term ended Apr 6, 2019 · From the USPTO record
Term endedTerm ended Apr 6, 2019From the USPTO record
US 8,114,906Essential Fatty Acids in the Treatment And/Or Inhibition of Depression in Patients with Coronary Heart or Artery Disease
Lapsed on the fee record
Ended Feb 14, 2016 · High confidence
Lapsed on the fee recordEnded Feb 14, 2016High confidence
US 7,309,706Method for the Treatment of Diseases Requiring Inhibition or a Reduction in the Activity of PH Value-Regulating Bicarbonate Transporter Proteins
Lapsed on the fee record
Ended Dec 18, 2015 · High confidence
Lapsed on the fee recordEnded Dec 18, 2015High confidence
US 7,087,620Liquid Pharmaceutical Formulations Containing 3,7-Diazabicyclo[3,3,1] Nonane Compounds and Methods of Treatment Relating to Anti-Arrhythmic Events
Lapsed on the fee record
Ended Aug 8, 2014 · High confidence
Lapsed on the fee recordEnded Aug 8, 2014High confidence
US 7,041,303Use of Moxonidine for Postmyocardial Infarction Treatment
Lapsed on the fee record
Ended May 9, 2014 · High confidence
Lapsed on the fee recordEnded May 9, 2014High confidence
US 5,183,821Method for treating leukemias using N-(2-dimethylaminoethyl)-3-amino-1,8-naphthalimide for treating leukemias and solid tumors
Formerly held
Term ended
Term ended no later than Feb 2, 2013 · Low confidence
Term endedTerm ended no later than Feb 2, 2013Low confidence
US 5,324,732Crystalline fumaric acid salts of 9,9-alkylene-3,7-diazabicyclononane compounds and pharmaceutical compositions containing them
Term ended
Term ended no later than Jun 28, 2014 · Low confidence
Term endedTerm ended no later than Jun 28, 2014Low confidence
US 5,712,283Method of inhibiting hyperglycemia and pharmaceutical composition for use therein
Term ended
Term ended no later than Jan 27, 2018 · Low confidence
Term endedTerm ended no later than Jan 27, 2018Low confidence
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited